Mutagenicity of tryptophan photoproducts in the Ames Salmonella assay. 1994

M Sjögren, and U Sjöberg, and U Rannug
Department of Genetic and Cellular Toxicology, Wallenberg Laboratory, Stockholm University, Sweden.

During the photolysis of tryptophan a large number of products is formed. In this study, aqueous solutions of tryptophan were irradiated by ultraviolet light during 5, 20 or 40 h. Each of the irradiated batches was divided into two aliquots, which were freeze-dried or extracted with chloroform. For each batch the latter extract was subsequently divided into a purified chloroform extract and a methanol extract. Aliquots of the purified chloroform extracts were fractionated and pooled, peakwise, into seven fractions. A recombined sample was also constructed. All extracts and samples were tested for mutagenicity using the standard Ames Salmonella assay. The results indicate an exposure time dependent increase in mutagenicity of the extracts, as seen with tester strain TA100 both with and without metabolic activation. The mutagenicity of the freeze-dried extracts well approximated the mutagenicity of the chloroform extracts, indicating that most mutagenicity can be extracted with chloroform. With the fractions the highest mutagenic responses were seen in the late, i.e., less lipophilic fractions. This response pattern seen in TA98 and TA100, mainly with S9 activation, was in contrast to the response of TA102 without S9, which was highest to the more lipophilic fractions. On a fraction level, no general exposure dependent increase of mutagenicity was observed. The results also show that photooxidation of tryptophan gives rise to a different spectrum of products compared to pyrolysis. Both processes result in compounds with strong biological effects. Photooxidation results in compounds with low genotoxicity and high Ah receptor affinity while pyrolysis generates compounds with high genotoxicity and low or no Ah receptor affinity.

UI MeSH Term Description Entries
D009152 Mutagenicity Tests Tests of chemical substances and physical agents for mutagenic potential. They include microbial, insect, mammalian cell, and whole animal tests. Genetic Toxicity Tests,Genotoxicity Tests,Mutagen Screening,Tests, Genetic Toxicity,Toxicity Tests, Genetic,Genetic Toxicity Test,Genotoxicity Test,Mutagen Screenings,Mutagenicity Test,Screening, Mutagen,Screenings, Mutagen,Test, Genotoxicity,Tests, Genotoxicity,Toxicity Test, Genetic
D009153 Mutagens Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. Clastogen,Clastogens,Genotoxin,Genotoxins,Mutagen
D010084 Oxidation-Reduction A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs (Lehninger, Principles of Biochemistry, 1982, p471). Redox,Oxidation Reduction
D010782 Photolysis Chemical bond cleavage reactions resulting from absorption of radiant energy. Photodegradation
D002725 Chloroform A commonly used laboratory solvent. It was previously used as an anesthetic, but was banned from use in the U.S. due to its suspected carcinogenicity. Trichloromethane
D005612 Freeze Drying Method of tissue preparation in which the tissue specimen is frozen and then dehydrated at low temperature in a high vacuum. This method is also used for dehydrating pharmaceutical and food products. Lyophilization,Drying, Freeze,Dryings, Freeze,Freeze Dryings,Lyophilizations
D006358 Hot Temperature Presence of warmth or heat or a temperature notably higher than an accustomed norm. Heat,Hot Temperatures,Temperature, Hot,Temperatures, Hot
D001711 Biotransformation The chemical alteration of an exogenous substance by or in a biological system. The alteration may inactivate the compound or it may result in the production of an active metabolite of an inactive parent compound. The alterations may be divided into METABOLIC DETOXICATION, PHASE I and METABOLIC DETOXICATION, PHASE II.
D012486 Salmonella typhimurium A serotype of Salmonella enterica that is a frequent agent of Salmonella gastroenteritis in humans. It also causes PARATYPHOID FEVER. Salmonella typhimurium LT2
D014364 Tryptophan An essential amino acid that is necessary for normal growth in infants and for NITROGEN balance in adults. It is a precursor of INDOLE ALKALOIDS in plants. It is a precursor of SEROTONIN (hence its use as an antidepressant and sleep aid). It can be a precursor to NIACIN, albeit inefficiently, in mammals. Ardeydorm,Ardeytropin,L-Tryptophan,L-Tryptophan-ratiopharm,Levotryptophan,Lyphan,Naturruhe,Optimax,PMS-Tryptophan,Trofan,Tryptacin,Tryptan,Tryptophan Metabolism Alterations,ratio-Tryptophan,L Tryptophan,L Tryptophan ratiopharm,PMS Tryptophan,ratio Tryptophan

Related Publications

M Sjögren, and U Sjöberg, and U Rannug
November 2000, Mutation research,
M Sjögren, and U Sjöberg, and U Rannug
January 1996, Anticancer research,
M Sjögren, and U Sjöberg, and U Rannug
July 1986, Fundamental and applied toxicology : official journal of the Society of Toxicology,
M Sjögren, and U Sjöberg, and U Rannug
April 2023, Environmental and molecular mutagenesis,
M Sjögren, and U Sjöberg, and U Rannug
January 1993, Environmental and molecular mutagenesis,
M Sjögren, and U Sjöberg, and U Rannug
January 1986, Progress in clinical and biological research,
M Sjögren, and U Sjöberg, and U Rannug
May 2001, Current protocols in toxicology,
M Sjögren, and U Sjöberg, and U Rannug
December 1995, Mutation research,
M Sjögren, and U Sjöberg, and U Rannug
January 1980, Mutation research,
M Sjögren, and U Sjöberg, and U Rannug
February 1983, Mutation research,
Copied contents to your clipboard!